• NIH announces public-private partnership to advance schizophrenia biomarker research

    6 days ago - By Healio

    The NIH this week announced the launch of Accelerating Medicine Partnership Schizophrenia, according to an institutional press release.
    The NIH and FDA, along with seven industry and nonprofit partners, aim to improve early therapeutic interventions and targeted treatments for schizophrenia with this initiative. Goals of the partnership include conducting research into biological markers to identify people at risk for developing schizophrenia, tracking outcomes like symptom progression and defining targets for treatment development.
    “We know that with most brain diseases, early
    Read more ...